abstract |
Disclosed is a substantially pure form of a compound of the formula (I), (II) or (III), an equilibrating form thereof or a pharmaceutically acceptable salt wherein the substituents are disclosed within the specification. Also disclosed is the use of a compound of formula (I), (II) or (III) in the preparation of a medicament for treatment of an individual with thrombocythemia. |